bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Orchestra BioMed Inc. logo

    Orchestra BioMed Inc.

    OBIO | NASDAQ
    Chart Builder DCF Calculator
    $6.31
    +$0.06 (+0.96%)
    Sep 22, 2026, 2:44 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $374.25M
    Enterprise Value
    $265.62M
    Beta
    0.53
    Average Volume
    321.32K
    Shares Outstanding (Diluted)
    63.81M
    Shares Change YoY
    66.21%
    Institutional Ownership
    36.82%
    Exchange
    NASDAQ
    ISIN
    US68572M1062

    Price Performance

    Price Change 1M
    16.8%
    Price Change 3M
    54.7%
    Price Change 6M
    36.8%
    Price Change YTD
    45.0%
    Price Change 1Y
    155.1%
    Price Change 3Y
    -27.2%
    Price Change 5Y
    -36.4%
    1M CAGR (ann.)
    47.4%
    1Y CAGR (ann.)
    149.0%
    5Y CAGR (ann.)
    -8.9%
    All-Time CAGR
    -9.3%

    Valuation

    PE Ratio
    -4.81
    Forward PE
    N/A
    PEG Ratio
    -0.10
    Forward PEG
    9.23
    PS Ratio
    11.70
    Forward PS
    654.80
    PB Ratio
    19.37
    P/FCF Ratio
    -6.33
    P/Adj. FCF Ratio
    -5.33
    P/OCF Ratio
    -6.87
    EV/Sales
    8.31
    EV/EBIT
    -4.62
    EV/EBITDA
    -4.65
    EV/FCF
    -4.49
    Earnings Yield
    -20.8%
    FCF Yield
    -15.8%
    Adj. FCF Yield
    -18.8%

    Financial Health

    Net Cash
    $108.64M
    Total Debt
    $1.33M
    Cash & Short-Term Investments
    $109.96M
    Total Assets
    $115.7M
    Current Ratio
    8.26
    Quick Ratio
    8.24
    Debt / Equity Ratio
    2.41
    Debt / EBITDA
    -0.02
    Debt / FCF
    -0.02
    OCF / Debt
    -43.92
    Interest Coverage
    -27.63
    Altman Z-Score
    -2.67
    Piotroski F-Score
    6

    Margins & Profitability

    Gross Profit Margin
    99.3%
    Operating Profit Margin
    -181.4%
    EBITDA Margin
    -178.6%
    Net Profit Margin
    -184.6%
    FCF Margin
    -184.8%
    Adj. FCF Margin
    -219.6%
    SBC / Revenue
    34.8%
    SBC Impact (per share)
    -18.8%

    Returns

    Return on Assets
    -51.0%
    Return on Equity
    -125.9%
    Return on Invested Capital
    -56.3%
    Return on Capital Employed
    -56.7%
    Return on Tangible Assets
    -51.0%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    94.5%
    Revenue CAGR 5Y
    148.4%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    8.6%
    EPS CAGR 5Y
    -6.9%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -13.2%
    FCF CAGR 5Y
    -20.1%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    6
    EPS Growth Next 3Y
    23.1%
    Revenue Growth Next 3Y
    16.6%
    Earnings Date
    Nov 8, 2026
    EPS Estimate (next Q)
    -$0.40
    EPS Growth Est (next Q)
    0.0%
    Revenue Est (next Q)
    $128K
    Revenue Growth Est (next Q)
    -85.1%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $11
    Price Target Upside
    76.0%

    Cash Flow

    Operating Cash Flow
    $-58.32M
    Free Cash Flow
    $-59.1M
    Adj. Free Cash Flow
    $-70.22M
    FCF Per Share
    -$0.93
    OCF Per Share
    -$0.91
    OCF/S Ratio
    -182.4%

    Income Statement

    Revenue
    $31.98M
    Gross Profit
    $31.76M
    Operating Income
    $-57.99M
    EBITDA
    $-57.1M
    Net Income
    $-59.03M
    EPS (Diluted)
    -$1.30
    Revenue / Employee
    $371.81K
    Profit / Employee
    $-686.38K
    Employees
    86

    © 2026 bestshares.com. All rights reserved.